Changes to the rules for determining the localization of pharmaceutical products and medical devices for the purposes of public procurement have come into effect in the EAEU.

Starting from January 22, new rules regarding the determination of the country of origin for certain goods in public procurement will come into effect in the countries of the Eurasian Economic Union. This information was announced by the Eurasian Economic Commission.

These changes will apply to relations arising from January 1, 2026.

A decision by the Council of the Eurasian Economic Commission dated November 19, 2025, which modifies the rules for certain categories of pharmaceutical and medical products participating in public procurement, has been published on the legal portal of the EAEU.

As a result of these changes, 56 product names will be added to the Eurasian Register of Industrial Goods. Among them, 31 products, including synthetic fibers, needles, prosthetics, urostomy bags, ultrasound scanners, medications, and pharmaceutical substances, will be included under certain production and technological process conditions. The remaining 25 items, such as medical masks, bandages, syringes, surgical materials, hearing aids, and fire extinguishers, will be added based on the ST-1 certificate.

Furthermore, the validity of Appendix No. 11 to the Rules will be extended until the end of 2026. This appendix contains a list of goods that can be included in the Eurasian Register of Industrial Goods based on the ST-1 certificate. However, for some types of products, the validity period will be limited to June 30, 2026.

The Eurasian Register of Industrial Goods is being created to ensure access to public procurement in the EAEU countries, where preferences, restrictions, and prohibitions regarding goods from other member states and third countries are in place. To be included in the Register, it is necessary to follow the established algorithm. {lang_tg} {lang_share_buttons}